Raisio Oyj Vaihto-osake

Raisio plc will release its Half-Year Financial Report for January-June 2024 on Wednesday, 7 August 2024, at approximately 8.30 am EEST. The report will be accessible on their website, www.raisio.com. A webcast for analysts, investors, and media, presented in Finnish by CEO Pasi Flinkman and CFO Mika Saarinen, will take place on the same day at 12.00 EEST. The webcast and its recording can be viewed at https://raisio.videosync.fi/q2-2024. An English presentation slide-deck will be available on their website after the webcast. For further information, contact CFO Mika Saarinen at +358 40 072 6808. Raisio plc focuses on producing plant-based and heart-healthy foods and exports to over 40 markets globally. In 2023, the company's comparable net sales for continuing operations were EUR 219.5 million, with a comparable EBIT of EUR 22.7 million. Raisio's shares are listed on Nasdaq Helsinki Ltd.

Raisio plc announced a manager's transaction involving Pekka Tennilä, a member of the Board. On June 18, 2024, Tennilä received a share-based incentive consisting of 1,654 shares, with a unit price of 0 EUR. Raisio plc, known for its plant-based and heart-healthy products under brands like Benecol®, Härkis®, and Elovena®, operates in over 40 markets worldwide. In 2023, Raisio's net sales for continuing operations were EUR 219.5 million, with a comparable EBIT of EUR 22.7 million. The company's shares are listed on Nasdaq Helsinki Ltd. For further information, contact CFO Mika Saarinen or CLO Sari Koivulehto-Mäkitalo.

Raisio plc announced the conveyance of its own shares as part of the reward for the Chairman and Board members, following a decision made at the Annual General Meeting in April 2024. Approximately 20% of the monthly reward will be paid in shares and 80% in cash, distributed in June and December. On June 18, 2024, Raisio assigned 11,485 shares (RAIVV) valued at EUR 1.922 per share, totaling EUR 22,074.17, to the Chairman and Board members. After this conveyance, Raisio holds 1,190,858 free shares. Raisio plc focuses on producing plant-based and heart-healthy food products, with strong brands like Benecol®, Härkis®, and Elovena®. The company operates in seven countries, exporting to over 40 markets, and is listed on Nasdaq Helsinki Ltd. In 2023, Raisio's net sales were EUR 219.5 million with an EBIT of EUR 22.7 million.

Raisio plc held its Annual General Meeting (AGM) on 9 April 2024. The AGM adopted the financial statements for the financial year 2023, discharged the members of the Board of Directors, Supervisory Board and the CEO from liability, and adopted the Remuneration Report and Policy. A dividend of EUR 0.14 per share will be paid on 18 April 2024. The Supervisory Board will have 25 members with new members elected and the annual remuneration for the Chairman confirmed at EUR 12,000. The Board of Directors will have six members, with new and re-elected members and the Chairman's monthly remuneration set at EUR 5,150. Ernst & Young Oy and Minna Viinikkala were re-elected as auditors. The AGM also authorised the Board to decide on the acquisition of the company’s own shares and on share issues. The minutes of the AGM will be available on the company’s website by 23 April 2024.